Home Resource Centers Biopharm Dev & Mfg Podcasts Will Outsourcing Continue As Long-Term Strategy For The Pharma Industry?
Friday, 06 April 2012 19:22

Will Outsourcing Continue As Long-Term Strategy For The Pharma Industry?

Tips From PriceWaterhouseCoopers’ Jan Paul Zonnenberg
Jan Paul Zonnenberg, partner, healthcare practice, PriceWaterhouseCoppers (PwC) provides insights into current trends with regard to outsourcing in the pharmaceutical industry. Zonnenberg addresses issues around whether to outsource or retain competencies internal. In addition, he discusses potential costs, risks and the role emerging markets play and continue to develop. Further, Zonnenberg discusses how outsourcing is impacting the role of different technologies within the pharmaceutical industry. Finally, he provides three tips for U.S. pharma companies to outsource effectively. This should serve as a primer on his upcoming presentation, May 22, 2012, at the International Contract Services Expo & Conference (iCSE) to be held at the Philadelphia Convention Center. For more information go to www.icse-usa.com.

Download Podcast (click on link to download)

Length: 9 min, 27 sec

Read 12267 times Last modified on Thursday, 26 April 2012 15:07
Published in Podcasts
More in this category: A Primer On What To Expect At DIA 2012 »

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...
Subscribe to this RSS feed

Podcasts

Subscribe to this RSS feed